tiprankstipranks
Trending News
More News >
Vivoryon Therapeutics AG (DE:05Y)
FRANKFURT:05Y
Germany Market

Vivoryon Therapeutics AG (05Y) Technical Analysis

Compare
37 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Vivoryon Therapeutics AG’s (05Y) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Vivoryon Therapeutics AG is a Buy.
Vivoryon Therapeutics AG’s (05Y) 20-Day exponential moving average is 1.48, while Vivoryon Therapeutics AG’s (05Y) share price is €1.63, making it a Sell.
Vivoryon Therapeutics AG’s (05Y) 50-Day exponential moving average is 1.51, while Vivoryon Therapeutics AG’s (05Y) share price is €1.63, making it a Sell.

Vivoryon Therapeutics AG (05Y) Pivot Points

Feb 16, 2026, 04:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.43
1.43
1.43
1.43
1.43
1.43
1.43
Fibonacci
1.43
1.43
1.43
1.43
1.43
1.43
1.43
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vivoryon Therapeutics AG (05Y) Moving Averages

Feb 16, 2026, 04:26 PM
Period
Simple
Exponential
MA5
1.43Buy
1.44Buy
MA10
1.45Sell
1.45Sell
MA20
1.49Sell
1.48Sell
MA50
1.51Sell
1.51Sell
MA100
1.57Sell
1.55Sell
MA200
1.57Sell
1.60Sell
Vivoryon Therapeutics AG’s (05Y) 10-Day exponential moving average is 1.45, while Vivoryon Therapeutics AG’s (05Y) share price is €1.63, making it a Sell.
Vivoryon Therapeutics AG’s (05Y) 100-Day exponential moving average is 1.55, while Vivoryon Therapeutics AG’s (05Y) share price is €1.63, making it a Sell.
Vivoryon Therapeutics AG’s (05Y) stock price is €1.63 and Vivoryon Therapeutics AG’s (05Y) 50-day simple moving average is 1.51, creating a Sell signal.
Vivoryon Therapeutics AG’s (05Y) stock price is €1.63 and Vivoryon Therapeutics AG’s (05Y) 100-day simple moving average is 1.57, creating a Sell signal.
Vivoryon Therapeutics AG’s (05Y) stock price is €1.63 and Vivoryon Therapeutics AG’s (05Y) 200-day simple moving average is 1.57, creating a Sell signal.

Vivoryon Therapeutics AG (05Y) Technical Indicators

Feb 16, 2026, 04:26 PM
Name
Value
Implied Action
RSI (14)
40.25
Neutral
STOCH (9,6)
17.63
Buy
STOCHRSI (14)
11.04
Buy
MACD (12,26)
-0.03
Buy
ADX (14)
17.39
Buy
Williams %R
-77.78
Buy
CCI (14)
-82.38
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
32.72
Neutral
ROC
-5.62
Sell
Vivoryon Therapeutics AG’s (05Y) Relative Strength Index (RSI) is 40.25, creating a Neutral signal.
Vivoryon Therapeutics AG’s (05Y) Trend Strength Indicator (ADX) is 17.39, creating a Buy signal.
Vivoryon Therapeutics AG’s (05Y) Commodity Channel Index (CCI) is -82.38, creating a Neutral signal.
Vivoryon Therapeutics AG’s (05Y) Price Rate of Change (ROC) is -5.62, creating a Sell signal.

FAQ

Is 05Y a Buy, Hold, or Sell?
Based on 05Y’s technical indicators, 05Y is a Sell.
    What is 05Y’s RSI (14)?
    05Y’s RSI (14) is 40.25, which suggests 05Y is a Neutral.
      What is 05Y’s MACD?
      05Y’s MACD is -0.03, which suggests 05Y is a Buy.
        What is 05Y’s 5-day moving average?
        05Y’s 5-day moving average is 1.43, which suggests 05Y is a Buy.
          What is 05Y’s 20-day moving average?
          05Y 20-day moving average is 1.49, which suggests 05Y is a Sell.
            What is 05Y’s 50-day moving average?
            05Y’s 50-day moving average is 1.51, which suggests 05Y is a Sell.
              What is 05Y’s 200-day moving average?
              05Y’s 200-day moving average is 1.57, which suggests 05Y is a Sell.
                What is 05Y’s Williams % R (14)?
                05Y’s Williams % R (14) is -77.78, which suggests 05Y is a Buy.
                  What is 05Y’s CCI (14)?
                  05Y’s CCI (14) is -82.38, which suggests 05Y is a Neutral.
                    What is the share price of Vivoryon Therapeutics AG?